Investigation into the molecular mechanisms underlying proteolysis of CDK inhibitor p27
CDK抑制剂p27蛋白水解的分子机制研究
基本信息
- 批准号:12213097
- 负责人:
- 金额:$ 35.97万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research on Priority Areas
- 财政年份:2000
- 资助国家:日本
- 起止时间:2000 至 2004
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
We have studied the mechamism underlying the regulation of the abundance of the CDK inhibitor p27. p27 is degraded at the GO-G1 transition, and its abundance remains low during cell proliferation. The SCF/Skp2 ubiquitin ligase complex has been thought to play a critical role in p27 degradation. However, analysis of Skp2-deficient mice revealed that degradation of p27 at the GO-G1 transition proceeds normally in Skp2-/-cells, whereas p27 proteolysis during S-G2 phases is impaired in these Skp2-deficient cells. These results suggested the presence of Skp2-independent pathway to control ubiquitination of p27 at the GO-G1 transition. Using in vitro ubiquitylation assay, we biochemically purified a complex consisting of two proteins, designated KPC (Kip1 ubiquitylation Promoting Complex)1 and KPC2. Given that KPC1/2 are localized in the cytoplasm, nuclear export of p27 seems to precede the ubiquitination by KPC1/2. Overexpression of wild-type KPC1/2 in mammalian cells promotes the degradation of p27, whereas expression of dominant-negative mutant KPC 1/2 delayed the degradation. Depletion of KPC1 by RNA interference also inhibited p27 degradation. These data suggest that KPC 1/2 ubiquitin ligase complex controls the degradation of p27 at the GO-G1 transition, whereas the major function of Skp2 may be the regulation of progression from G2 to M phase by mediating the degradation of p27.
我们研究了CDK抑制剂p27丰度调节的潜在机制。p27在GO-G1转换时降解,并且其丰度在细胞增殖期间保持较低。SCF/Skp 2泛素连接酶复合物被认为在p27降解中起关键作用。然而,对Skp 2缺陷小鼠的分析显示,在Skp 2-/-细胞中,GO-G1转换时p27的降解正常进行,而在这些Skp 2缺陷细胞中,S-G2期期间p27蛋白水解受损。这些结果表明存在Skp 2非依赖性途径来控制p27在GO-G1转换时的泛素化。使用体外泛素化测定,我们生化纯化的复合物由两种蛋白质,命名为KPC(Kip 1泛素化促进复合物)1和KPC 2。鉴于KPC 1/2定位于细胞质中,p27的核输出似乎先于KPC 1/2的泛素化。野生型KPC 1/2在哺乳动物细胞中的过表达促进p27的降解,而显性阴性突变体KPC 1/2的表达延迟了降解。通过RNA干扰去除KPC 1也抑制p27降解。这些数据表明,KPC 1/2泛素连接酶复合物控制p27在GO-G1转换时的降解,而Skp 2的主要功能可能是通过介导p27的降解来调节从G2到M期的进展。
项目成果
期刊论文数量(120)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Skp2-mediated degradation of p27 regulates progression into mitosis
- DOI:10.1016/s1534-5807(04)00131-5
- 发表时间:2004-05-01
- 期刊:
- 影响因子:11.8
- 作者:Nakayama, K;Nagahama, H;Nakayama, KI
- 通讯作者:Nakayama, KI
Kanematsu, T. et al.: "Role of the PLC-related, catalytically inactive protein p130 in GABA_A receptor function"EMBO J.. 21. 1004-1011 (2002)
Kanematsu, T. 等人:“PLC 相关的催化失活蛋白 p130 在 GABA_A 受体功能中的作用”EMBO J.. 21. 1004-1011 (2002)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Nagahama, H.: "Spatial and temporal expression patterns of the cyclin-dependent kinase (CDK) inhibitors p27^<Kip1> and p57^<Kip2> during mouse development"Anat. Embryol. 203. 77-87 (2001)
Nagahama, H.:“小鼠发育过程中细胞周期蛋白依赖性激酶 (CDK) 抑制剂 p27^<Kip1> 和 p57^<Kip2> 的空间和时间表达模式”Anat。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
NAKAYAMA Keiichi其他文献
NAKAYAMA Keiichi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('NAKAYAMA Keiichi', 18)}}的其他基金
Elucidation of Warburg effect in cancer with the next-generation proteomics
用下一代蛋白质组学阐明癌症中的 Warburg 效应
- 批准号:
26640080 - 财政年份:2014
- 资助金额:
$ 35.97万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Deciphering the role of protrudin regulating neuronal vesicular transport
破译protrudin调节神经元囊泡运输的作用
- 批准号:
22240038 - 财政年份:2010
- 资助金额:
$ 35.97万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Deciphering the mechanisms underlying cancer development induced by deregulation of proteolysis
破译蛋白水解失调诱导癌症发展的机制
- 批准号:
17013067 - 财政年份:2005
- 资助金额:
$ 35.97万 - 项目类别:
Grant-in-Aid for Scientific Research on Priority Areas
Isolation and characterization of protrudin, a master regulator of neurite formation
神经突形成的主要调节因子 protrudin 的分离和表征
- 批准号:
17107004 - 财政年份:2005
- 资助金额:
$ 35.97万 - 项目类别:
Grant-in-Aid for Scientific Research (S)
Analysis of the PKC-δ Signaling Pathway by Proteomics with Embryonic and Genetic Engeneering
胚胎和基因工程蛋白质组学分析 PKC-δ 信号通路
- 批准号:
15370060 - 财政年份:2003
- 资助金额:
$ 35.97万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
New cancer therapy by degradation of specific proteins
通过降解特定蛋白质的新癌症疗法
- 批准号:
13557019 - 财政年份:2001
- 资助金额:
$ 35.97万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
New clearance system of abnormal protein in Polyglutammine disease
多聚谷氨酰胺病异常蛋白的新清除系统
- 批准号:
13480258 - 财政年份:2001
- 资助金额:
$ 35.97万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Studies on the construction of a system of water management in the greening process of land.
土地绿化过程中水管理体系构建研究
- 批准号:
07456118 - 财政年份:1995
- 资助金额:
$ 35.97万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Studies on the development of model to estimate the soil moisture with AMeDAS data
利用AMeDAS数据估算土壤湿度模型的开发研究
- 批准号:
63560248 - 财政年份:1988
- 资助金额:
$ 35.97万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
相似海外基金
Elucidating the mechanisms of CDK inhibitor resistance in cancer using chemical proteomics
利用化学蛋白质组学阐明癌症中 CDK 抑制剂耐药性的机制
- 批准号:
9905310 - 财政年份:2019
- 资助金额:
$ 35.97万 - 项目类别:
Elucidating the mechanisms of CDK inhibitor resistance in cancer using chemical proteomics
利用化学蛋白质组学阐明癌症中 CDK 抑制剂耐药性的机制
- 批准号:
9761209 - 财政年份:2019
- 资助金额:
$ 35.97万 - 项目类别:
RPS14 a CDK inhibitor deleted in myelodysplastic syndrome
RPS14 是一种在骨髓增生异常综合征中缺失的 CDK 抑制剂
- 批准号:
498723-2016 - 财政年份:2016
- 资助金额:
$ 35.97万 - 项目类别:
University Undergraduate Student Research Awards
Antitumor effect of CDK inhibitor in mesothelioma
CDK抑制剂对间皮瘤的抗肿瘤作用
- 批准号:
15K10283 - 财政年份:2015
- 资助金额:
$ 35.97万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Treatment of pituitary Cushing disease with a selective CDK inhibitor, R-roscovit
用选择性 CDK 抑制剂 R-roscovit 治疗垂体库欣病
- 批准号:
8773516 - 财政年份:2014
- 资助金额:
$ 35.97万 - 项目类别:
精子幹細胞の自己複製制御におけるCDK inhibitorの役割の解明
阐明CDK抑制剂在控制精子干细胞自我更新中的作用
- 批准号:
25291052 - 财政年份:2013
- 资助金额:
$ 35.97万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Effect of Cdk inhibitor on HIV-1 replication
Cdk 抑制剂对 HIV-1 复制的影响
- 批准号:
7230046 - 财政年份:2006
- 资助金额:
$ 35.97万 - 项目类别:
Effect on cdk inhibitor in HIV-1 replication
cdk 抑制剂对 HIV-1 复制的影响
- 批准号:
7064170 - 财政年份:2006
- 资助金额:
$ 35.97万 - 项目类别:
Degradation of the CDK inhibitor p27^<Kip1> by a novel ubiquitin ligase.
新型泛素连接酶降解 CDK 抑制剂 p27^<Kip1>。
- 批准号:
17590243 - 财政年份:2005
- 资助金额:
$ 35.97万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
CDK inhibitor regulation during the Xenopus cell cycle
非洲爪蟾细胞周期中 CDK 抑制剂的调节
- 批准号:
6613583 - 财政年份:2003
- 资助金额:
$ 35.97万 - 项目类别: